Literature DB >> 28063651

Recent Highlights in Psoriasis Research.

Samuel T Hwang1, Tamar Nijsten2, James T Elder3.   

Abstract

This article highlights recent advances in the immunology, epidemiology, and genetics/genomics of psoriasis. Advances sometimes generate more questions, and this article makes an attempt to point out where controversies might exist in the literature. Many of the articles mentioned were published in the Journal of Investigative Dermatology, but many articles from the broader scientific literature are also cited, to provide context and to add further validity for some of these key findings. Among the themes we explore are the identification of antigens in psoriasis, the co-morbidities of psoriasis, and novel integrative approaches to genome-wide association studies.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28063651     DOI: 10.1016/j.jid.2016.11.007

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  21 in total

1.  Regulatory annotation of genomic intervals based on tissue-specific expression QTLs.

Authors:  Tianlei Xu; Peng Jin; Zhaohui S Qin
Journal:  Bioinformatics       Date:  2020-02-01       Impact factor: 6.937

2.  Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis.

Authors:  Marta Consuegra-Fernández; Marc Julià; Mario Martínez-Florensa; Fernando Aranda; Cristina Català; Noelia Armiger-Borràs; María-Teresa Arias; Francisca Santiago; Antonio Guilabert; Anna Esteve; Carlos Muñoz; Carlos Ferrándiz; José-Manuel Carrascosa; Edurne Pedrosa; Jorge Romaní; Mercè Alsina; José-Manuel Mascaró-Galy; Francisco Lozano
Journal:  Cell Mol Immunol       Date:  2017-12-11       Impact factor: 11.530

3.  Short-Term Exposure to a Western Diet Induces Psoriasiform Dermatitis by Promoting Accumulation of IL-17A-Producing γδ T Cells.

Authors:  Zhenrui Shi; Xuesong Wu; Sebastian Yu; Mindy Huynh; Prasant Kumar Jena; Mimi Nguyen; Yu-Jui Yvonne Wan; Samuel T Hwang
Journal:  J Invest Dermatol       Date:  2020-02-10       Impact factor: 8.551

4.  Management of psoriatic patients in biologic treatment associated with infectious comorbidities.

Authors:  Bernardini Nicoletta; Narcisi Alessandra; Skroza Nevena; Ersilia Tolino; Daniela Colapietra; Mastroianni Claudio; Potenza Concetta
Journal:  Postepy Dermatol Alergol       Date:  2020-07-16       Impact factor: 1.837

5.  Diet-induced obesity exacerbates imiquimod-mediated psoriasiform dermatitis in anti-PD-1 antibody-treated mice: Implications for patients being treated with checkpoint inhibitors for cancer.

Authors:  Sebastian Yu; Xuesong Wu; Zhenrui Shi; Mindy Huynh; Prasant Kumar Jena; Lili Sheng; Yan Zhou; Dan Han; Yu-Jui Yvonne Wan; Samuel T Hwang
Journal:  J Dermatol Sci       Date:  2020-01-24       Impact factor: 4.563

6.  Serum Levels of miR-146a in Patients with Psoriasis.

Authors:  Bárbara Leal; Cláudia Carvalho; Ana Marta Ferreira; Miguel Nogueira; Sandra Brás; Berta M Silva; Manuela Selores; Paulo P Costa; Tiago Torres
Journal:  Mol Diagn Ther       Date:  2021-05-02       Impact factor: 4.074

7.  Gene interaction analysis of psoriasis in Chinese Han population.

Authors:  Qiongqiong Xu; Xiaodong Zheng; Yiwen Mao; Weiwei Chen; Shirui Chen; Hui Zhang; Qi Zhen; Bao Li; Liang Yong; Huiyao Ge; Yafen Yu; Ruixue Zhang; Lu Cao; Hui Cheng; Wenjun Wang; Liangdan Sun
Journal:  Mol Genet Genomic Med       Date:  2022-03-30       Impact factor: 2.473

8.  PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-κB and production of inflammatory cytokines.

Authors:  Rongkun Dou; Zongying Liu; Xue Yuan; Danzhou Xiangfei; Ruixue Bai; Zhenfei Bi; Piao Yang; Yalan Yang; Yinsong Dong; Wei Su; Diqiang Li; Canquan Mao
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

Review 9.  Psoriasis: Obesity and Fatty Acids.

Authors:  Manfred Kunz; Jan C Simon; Anja Saalbach
Journal:  Front Immunol       Date:  2019-07-31       Impact factor: 7.561

10.  IL-35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells.

Authors:  Yuan Wang; Ying Mao; Junfeng Zhang; Gang Shi; Lin Cheng; Yi Lin; Yiming Li; Xiaomei Zhang; Yujing Zhang; Xiaolei Chen; Jie Deng; Xiaolan Su; Lei Dai; Yang Yang; Shuang Zhang; Dechao Yu; Yuquan Wei; Hongxin Deng
Journal:  J Cell Mol Med       Date:  2017-11-29       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.